BRCA2 and embryonal neoplasm: Patients with biallelic PVs in FANCD1/BRCA2 and FANCN/PALB2 have very high risks of malignancies, and they can develop embryonal tumors which are not seen in patients with FA who have PVs in other FANC genes.